DGX logo Quest Diagnostics : DGX

DGX

Stock Data

$238.63

Change up

$0.13 (0.05%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DIAGNOSTICS & RESEARCH

Quest Diagnostics is a leading provider of diagnostic testing and services globally. With a focus on delivering comprehensive diagnostic information through routine, advanced clinical, and anatomic pathology testing, it serves a wide range of clients including physicians, hospitals, patients, health plans, and government agencies. Operating under the Quest Diagnostics brand and others like AmeriPath and ExamOne, it has a vast network of laboratories and patient service centers. Additionally, it offers risk assessment services for the life insurance industry and IT solutions for healthcare organizations. Founded in 1967, Quest is headquartered in Secaucus, New Jersey.

Latest Activity

DGXQuest Diagnostics
Q2 2026
EPS
$3.12
est $2.82+10.5%
Revenue
$3.04B
est $2.97B+2.4%

Quest Diagnostics crushed Q2 earnings with a 10.5% EPS beat fueled by a 13.1% surge in testing volume, lifting the company's full-year guidance on broad momentum in Alzheimer's blood tests and cancer diagnostics.

Quarterly EPS — reported vs estimate

All Quest Diagnostics Articles

98 Articles

1 2 3 7